Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
Background: Although the seasonal and perennial malaria chemopreventions are not implemented in the Republic of Congo, resistance to Sulfadoxine-pyrimethamine (SP) threatens the intermittent preventive treatment during pregnancy (IPTp-SP) and others treatments using the drug. The objective of this s...
Saved in:
| Main Authors: | Jean Claude Djontu, Marcel Tapsou Baina, Jacque Dollon Mbama Ntabi, Abel Lissom, Dieu Merci Umuhoza, Naura veil Assioro Doulamo, Christevy Jeanney Vouvoungui, Reauchelvy Kamal Boumpoutou, Alain Maxime Mouanga, Etienne Nguimbi, Francine Ntoumi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal for Parasitology: Drugs and Drug Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320724000502 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01) -
A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.
Published: (2025-02-01) -
Projected uptake of sulfadoxine–pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis
by: Céline Audibert, et al.
Published: (2025-04-01) -
Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey
by: Elihuruma Eliufoo Stephano, et al.
Published: (2025-07-01) -
Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 2; peer review: 3 approved]
by: Isabella Oyier, et al.
Published: (2025-04-01)